Indaptus Historical Income Statement
| INDP Stock | USD 1.16 0.01 0.85% |
Historical analysis of Indaptus Therapeutics income statement accounts such as Selling General Administrative of 5.3 M or Selling And Marketing Expenses of 1.1 K can show how well Indaptus Therapeutics performed in making a profits. Evaluating Indaptus Therapeutics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Indaptus Therapeutics's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Indaptus Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Indaptus Therapeutics is a good buy for the upcoming year.
Indaptus |
About Indaptus Income Statement Analysis
Indaptus Therapeutics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Indaptus Therapeutics shareholders. The income statement also shows Indaptus investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Indaptus Therapeutics Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Indaptus Therapeutics. It is also known as Indaptus Therapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from Indaptus Therapeutics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Indaptus Therapeutics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Indaptus Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. To learn how to invest in Indaptus Stock, please use our How to Invest in Indaptus Therapeutics guide.At this time, Indaptus Therapeutics' Interest Expense is relatively stable compared to the past year. As of 10/06/2024, Total Other Income Expense Net is likely to grow to about 1 M, while Gross Profit is likely to drop (1.3 K).
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 17.7K | 588.1K | 676.3K | 710.1K | Depreciation And Amortization | 1.4K | 1.8K | 1.3K | 1.2K |
Indaptus Therapeutics income statement Correlations
Click cells to compare fundamentals
Indaptus Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pair Trading with Indaptus Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Indaptus Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Indaptus Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Indaptus Stock
Moving against Indaptus Stock
| 0.85 | BMY | Bristol Myers Squibb | PairCorr |
| 0.84 | ZTS | Zoetis Inc | PairCorr |
| 0.84 | GILD | Gilead Sciences | PairCorr |
| 0.74 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.74 | PAHC | Phibro Animal Health | PairCorr |
The ability to find closely correlated positions to Indaptus Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Indaptus Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Indaptus Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Indaptus Therapeutics to buy it.
The correlation of Indaptus Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Indaptus Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Indaptus Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Indaptus Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Indaptus Stock Analysis
When running Indaptus Therapeutics' price analysis, check to measure Indaptus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Indaptus Therapeutics is operating at the current time. Most of Indaptus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Indaptus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Indaptus Therapeutics' price. Additionally, you may evaluate how the addition of Indaptus Therapeutics to your portfolios can decrease your overall portfolio volatility.